Seahorse Bioscience
Latest round
- Series E
Last raised
- May 2012
Total raised
- $22M
Investors
- 9
About Seahorse Bioscience
Seahorse Bioscience, Inc.Seahorse Bioscience, Inc. is dedicated to providing innovative solutions for cell analysis. Founded by Andrew Neilson, the company was acquired by Agilent Technologies in November 2015.Seahorse Bioscience delivers cutting-edge instruments for cell analysis, including the Agilent Seahorse XF platform, which provides real-time metabolic analysis. Their offerings are vital for research in cancer biology, drug discovery, and cardiovascular studies.Seahorse Bioscience generates revenue primarily from the sale of analytical instruments and software solutions, complemented by ongoing service agreements. Their business model includes direct B2B sales to research institutions and pharmaceutical firms, alongside subscription offerings for software and training services. The company is currently working on launching advanced versions of its cell analysis technologies, targeting release dates in the upcoming quarters. There are specific plans to strengthen its presence in Europe and Asia-Pacific by 2025, aiming to increase market share and support researchers with innovative solutions that enhance experimental outcomes.
Who invested in Seahorse Bioscience
9 investors across 4 rounds
See all investors in Seahorse Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Seahorse Bioscience
Who invested in Seahorse Bioscience?
Seahorse Bioscience has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Seahorse Bioscience raised?
Seahorse Bioscience has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Seahorse Bioscience last raise money?
Seahorse Bioscience's most recent round on record is a Series E, in May 2012.
What does Seahorse Bioscience do?
Seahorse Bioscience is a biotechnology company.
Where is Seahorse Bioscience headquartered?
Seahorse Bioscience is headquartered in Billerica, US.
Which VCs invest in companies like Seahorse Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seahorse Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Seahorse Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.